Skip to content

Effect of Sesame Oil in Preventing Phlebitis

The Effect of Sesame Oil on the Prevention of Phlebitis in Patients Undergoing Cardiac Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05326568
Enrollment
44
Registered
2022-04-13
Start date
2023-06-15
Completion date
2023-10-15
Last updated
2023-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Phlebitis After Infusion

Keywords

aromatherapy, amiodarone infusion, phlebitis, cardiac surgery, Sesame oil

Brief summary

Background: To determine the effect of sesame oil in preventing phlebitis that may occur during intravenous therapy in patients undergoing cardiac surgery. Material and Method: A randomized controlled interventional study will be conducted with patients treated in the coronary intensive care unit of a university hospital. The population of the study will be the patients hospitalized in the intensive care unit after cardiac surgery and administered parenteral amiodarone infusion. The power analysis was carried out by taking the study by. The sample size was determined as 44 patients. Personal Information Form and Visual Infusion Phlebitis Scale will be used to collect data. Sesame oil will be applied to the patients in the intervention group as 10 drops, 10 cm around the cannula, for 10 minutes. This administration will be repeated every eight hours during the 24-hour amiodarone infusion. No application will be made by the researcher to the patients in the control group. At the end of each 24 hours, patients in both groups will be evaluated by the investigator on the Visual Infusion Phlebitis Scale. Descriptive statistics, chi square, independent t test and Fisher's exact test will be used to evaluate the data.

Detailed description

No application was made to the patients assigned to the control group. Sesame oil was applied by the researcher to the patients assigned to the intervention group. Sesame oil was applied to the 10 cm circumference of the cannula by applying 10 drops and 10 minutes. This application was repeated every eight hours during the 24-hour amiodarone infusion. The area where the intravenous line is located is covered with a standard transparent dressing (Tegaderm) so that it can be observed. Patients in the intervention and control groups were evaluated for phlebitis at the end of every 24 hours (1st day, 2nd day, 3rd day) according to the VIP scale. The highest of the phlebitis stages obtained as a result of the evaluation was accepted as the final evaluation.

Interventions

OTHERComplementary treatment practice

Applying sesame oil to the patients assigned to the intervention group by applying 10 drops to the 10 cm circumference of the cannula for 10 minutes

Sponsors

Cukurova University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

After the research report is written, a third person will assign an intervention and control group to the letters.

Intervention model description

Prospective, parallel, two-arm randomized controlled clinical trial

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients who had undergone cardiac surgery, * were over 18 years old, * were conscious, could communicate, * were not allergic to sesame, * were administered prophylactic rhythm regulator * amiodarone as a treatment were included in the study.

Exclusion criteria

* who was with cancer, * who was with diabetes mellitus, * who was with hypertension * who was with peripheral vascular disease * Patients who had myocardial infarction during the procedure, * Received immunosuppressive therapy, * underwent resuscitation and could not use an intravenous catheter for any reason

Design outcomes

Primary

MeasureTime frameDescription
Visual Infusion Phlebitis ScaleChange from 1st day to 2nd day, and 3rd day after the implementationThe scale monitors the potential risks of the catheter when administering peripheral venous therapy and rates the developmental stages of phlebitis. Scores range from 0-4. A score of zero indicates that there are no signs of phlebitis, and a score of four indicates that the phlebitis is in the last stage.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026